Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000892569-03-000607
Filing Date
2003-03-07
Accepted
2003-03-07 15:20:11
Documents
9
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a87286e10vk.htm 10-K 944185
3 EXHIBIT 3.1 a87286exv3w1.txt EX-3.1 26900
4 EXHIBIT 3.2 a87286exv3w2.txt EX-3.2 1760
5 EXHIBIT 3.4 a87286exv3w4.txt EX-3.4 8544
6 EXHIBIT 10.37 a87286exv10w37.txt EX-10.37 57735
7 EXHIBIT 10.38 a87286exv10w38.txt EX-10.38 57393
8 EXHIBIT 23.1 a87286exv23w1.txt EX-23.1 1122
9 EXHIBIT 99.1 a87286exv99w1.txt EX-99.1 1106
10 EXHIBIT 99.2 a87286exv99w2.txt EX-99.2 1059
  Complete submission text file 0000892569-03-000607.txt   1102332
Mailing Address 15279 ALTON PARKWAY 100 IRVINE CA 92618
Business Address 15279 ALTON PARKWAY 100 IRVINE CA 92618 9497886000
ISTA PHARMACEUTICALS INC (Filer) CIK: 0000930553 (see all company filings)

EIN.: 330511719 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31255 | Film No.: 03596232
SIC: 2835 In Vitro & In Vivo Diagnostic Substances